Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07199660 · ClinicalTrials.gov registry record · NA
Reactions to Social Media Warning Labels Among Teens and Young Adults
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,012
- Enrollment target
NCT07199660: Completed NA study, sponsored by Stanford University.
NCT07199660 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,012 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07199660, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,012 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate whether social media warnings are perceived as more effective than control labels among teens and young adults, and to identify the most promising topics for social media warnings for these age groups. A secondary objective is to compare perceived message effectiveness of warnings refined using artificial intelligence (AI) vs. those not refined using AI.
Primary Outcome
The study will assess perceived message effectiveness for discouraging social media use with 1 item: "How much does this message discourage you from wanting to use social media?" Response options will range from "Not at all" (coded as 1) to "A great deal" (coded as 5). Higher scores indicate higher perceived message effectiveness.
Interventions
- BEHAVIORAL Human-developed negative body image warning
- BEHAVIORAL Voluntary warning
- BEHAVIORAL Human-developed depression and anxiety warning
- BEHAVIORAL Human-developed addiction warning
- BEHAVIORAL Human-developed sleep warning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,012 participants |
| Start Date | 2025-12-02 |
| Est. Completion | 2025-12-16 |
| Phase | NA |
What the finished NCT07199660 record still lists
NCT07199660 is an interventional study that assigns participants to a tested intervention. Its 1,012 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 5 interventions - of which Human-developed negative body image warning is the first listed.
NCT07199660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07199660 about?
NCT07199660 is a clinical study titled "Reactions to Social Media Warning Labels Among Teens and Young Adults". The primary objective of this study is to evaluate whether social media warnings are perceived as more effective than control labels among teens and young adults, and to identify the most promising topics for social media warnings for these age groups. A secondary objective is to compare perceived m...
What is the current status of trial NCT07199660?
This trial is currently completed. It is a NA study. The enrollment target is 1,012 participants. The study started on 2025-12-02. Estimated completion is 2025-12-16.
What interventions are being tested in trial NCT07199660?
The interventions under investigation include: Human-developed negative body image warning (BEHAVIORAL), Voluntary warning (BEHAVIORAL), Human-developed depression and anxiety warning (BEHAVIORAL), Human-developed addiction warning (BEHAVIORAL), Human-developed sleep warning (BEHAVIORAL).
Who is sponsoring clinical trial NCT07199660?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07199660's enrollment target sits among peer trials
1,012 106th of 2000 higher than 1,895 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI